Consumer pressure is high, RFK Jr has a megaphone, and retailers want clean labels regardless of what FDA says
The STEP 1 trial data at 68 weeks (approximately 16 months) showed that 32% of participants lost 20% or more of their starting weight
Z.SantosA.GuadagniniD.AssalinH
Dose-finding RCT of diabetic patients (N = 1210) given either GLP1/GIP medication weekly or PC: After 68 weeks, mean weight loss was 10% ( GLP1/GIP medication ), 7% (lower dose GLP1/GIP medication ), and 3% (PC)
The QR678 formulation, for example, has included vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-1, keratinocyte growth factor and copper tripeptide-1
In contrast to RCTs, retrospective observational studies offer the benefit of capturing extensive patient data in real-world settings